Abstract
Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Current Psychopharmacology
Title:Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target
Volume: 2
Author(s): Stefano Pallanti, Giacomo Grassi, Tommaso Tofani and Silvia Spitoni
Affiliation:
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Abstract: Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Export Options
About this article
Cite this article as:
Pallanti Stefano, Grassi Giacomo, Tofani Tommaso and Spitoni Silvia, Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113029990002
DOI https://dx.doi.org/10.2174/22115560113029990002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SPECT Radiopharmaceuticals for Dementia
Current Radiopharmaceuticals Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data
CNS & Neurological Disorders - Drug Targets Recent Advances in Progressive Supranuclear Palsy: A Review
Current Alzheimer Research Neuropharmacology of Vestibular System Disorders
Current Neuropharmacology Allosteric Modulation of Muscarinic Acetylcholine Receptors
Current Neuropharmacology Nicotinic Agonists and Psychosis
Current Drug Targets - CNS & Neurological Disorders Imaging Studies in Focal Dystonias: A Systems Level Approach to Studying a Systems Level Disorder
Current Neuropharmacology Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Current Medicinal Chemistry Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy
Central Nervous System Agents in Medicinal Chemistry Half a Century of l-DOPA
Current Topics in Medicinal Chemistry Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment
Current Medicinal Chemistry Galanin/GALP Receptors and CNS Homeostatic Processes
CNS & Neurological Disorders - Drug Targets Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Melatonin-mitochondria Interplay in Health and Disease
Current Topics in Medicinal Chemistry Recent Advances on α-Synuclein Cell Biology: Functions and Dysfunctions
Current Molecular Medicine Peripheral Biomarkers to Assess Suicide Risk
Current Psychiatry Reviews PET Imaging in Clinical Drug Abuse Research
Current Pharmaceutical Design Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets On the Existence of a Global Molecular Network Enmeshing the Whole Central Nervous System: Physiological and Pathological Implications
Current Protein & Peptide Science The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets